dimyristoylphosphatidylcholine has been researched along with oxadiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brian, AA; McConnell, HM; Thompson, NL | 1 |
| Alecio, MR; Golan, DE; Rando, RR; Veatch, WR | 1 |
| Graham, A; Owen, JS; Riddell, DR | 1 |
3 other study(ies) available for dimyristoylphosphatidylcholine and oxadiazoles
| Article | Year |
|---|---|
Covalent linkage of a synthetic peptide to a fluorescent phospholipid and its incorporation into supported phospholipid monolayers.
Topics: 4-Chloro-7-nitrobenzofurazan; Amino Acid Sequence; Cell Membrane; Diffusion; Dimyristoylphosphatidylcholine; Dinitrofluorobenzene; Immunoglobulin G; Membranes, Artificial; Microscopy, Fluorescence; Oligopeptides; Oxadiazoles; Phosphatidylethanolamines; Spectrophotometry, Ultraviolet; Succinimides | 1984 |
Use of a fluorescent cholesterol derivative to measure lateral mobility of cholesterol in membranes.
Topics: 4-Chloro-7-nitrobenzofurazan; Cholesterol; Diffusion; Dimyristoylphosphatidylcholine; Liposomes; Models, Biological; Molecular Conformation; Oxadiazoles; Phosphatidylcholines; Spectrometry, Fluorescence | 1982 |
Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.
Topics: 1-Methyl-3-isobutylxanthine; Apolipoproteins E; Arginine; Blood Platelets; Cholesterol; Cyclic AMP; Cyclic GMP; Dimyristoylphosphatidylcholine; Enzyme Inhibitors; Guanylate Cyclase; Humans; Lipoproteins, HDL; Membrane Lipids; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines | 1997 |